FDA Inspection 1105837 — Biomat USA
The FDA completed an inspection of Biomat USA on Sep 12, 2019 in Meridian, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Meridian, MS (United States)